gout

Krystexxa shows signs of life as Horizon keeps pushing sales force expansion
Fierce Pharma
Wed, 10/11/17 - 11:20 am
Krystexxa
Horizon Pharma
drug reps
gout
Ironwood zeroes in on primary care doctors with new gout combo med Duzallo
Fierce Pharma
Wed, 08/23/17 - 11:15 am
Ironwood Pharmaceuticals
gout
Duzallo
primary care
Ironwood looks to boost gout franchise as FDA delivers OK for Duzallo
Endpoints
Mon, 08/21/17 - 09:40 am
Ironwood
gout
FDA
Duzallo
AZ jilts gout med Zurampic with $230M rights sale to Grunenthal
Fierce Pharma
Thu, 06/2/16 - 04:03 pm
AstraZeneca
gout
Zurampic
Grunenthal
AstraZeneca hands off Zurampic marketing rights to Ironwood for $100 million
BioPharma Dive
Wed, 04/27/16 - 02:11 pm
AstraZeneca
Zurampic
Ironwood Pharmaceuticals
gout
AstraZeneca bags EU approval for gout drug Zurampic as it eyes $500M in sales
Fierce Pharma
Sat, 02/20/16 - 09:16 am
AstraZeneca
Europe
gout
Zurampic
Brilique
Aiming for $250M in sales, Horizon quadruples force behind gout med Krystexxa
Fierce Pharma Marketing
Mon, 01/25/16 - 11:13 am
drug reps
Horizon Pharma
Krystexxa
gout
AstraZeneca bags FDA OK on gout drug lesinurad as safety doubts linger
Fierce Biotech
Wed, 12/23/15 - 11:14 am
AstraZeneca
FDA
lesinurad
gout
AstraZeneca Presents Positive Update on Lesinurad Renal Data in Gout Patients
Yahoo
Mon, 11/9/15 - 09:57 am
AstraZeneca
lesinurad
gout
AstraZeneca's gout drug wins faint praise from FDA advisers
Fierce Biotech
Fri, 10/23/15 - 05:05 pm
AstraZeneca
gout
FDA
Zurampic
FDA reviewers question safety of AstraZeneca's gout drug
Yahoo/Reuters
Wed, 10/21/15 - 11:35 am
FDA
gout
AstraZeneca
lesinurad
2,000% Drug Price Surge Is a Side Effect of FDA Safety Program
Bloomberg
Tue, 10/6/15 - 08:15 am
Teva Pharmaceutical
Colcrys
FDA
gout
drug pricing
Study says no good has come from FDA's action on gout drug colchicine
Fierce Pharma
Sat, 04/11/15 - 10:24 am
FDA
gout
Colcrys
AstraZeneca gets pipeline boost from good gout drug results
Yahoo/AP
Wed, 08/13/14 - 08:12 am
gout
AstraZeneca
lesinurad
Demon Disease Targeted by AstraZeneca as Gout Rates Soar
Bloomberg
Fri, 02/14/14 - 12:58 pm
gout
AstraZeneca
lesinurad
AstraZeneca gets some good news for its late-stage gout therapy
Fierce Biotech
Fri, 12/13/13 - 10:53 am
gout
AstraZeneca’s
lesinurad
Savient Pharmaceuticals: Is Anything Left?
Seeking Alpha
Tue, 03/26/13 - 10:29 am
Krystexxa
Savient
gout
Savient Pharma: Still Struggling To Grow KRYSTEXXA Sales
Seeking Alpha
Wed, 11/21/12 - 10:44 am
Savient
Krystexxa
gout
Savient Receives Positive CHMP Opinion for Krystexxa Approval in the EU
Equities.com
Sat, 10/20/12 - 10:54 am
Krystexxa
Savient
gout
FDA rejects expanded use of Regeneron drug for gout
Reuters
Tue, 07/31/12 - 11:06 am
Regeneron
gout
FDA
Arcalyst

Pages